Detalles de la búsqueda
1.
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial.
Am Heart J
; 237: 54-61, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722585
2.
Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the influenza season 2021/22.
Influenza Other Respir Viruses
; 17(1): e13071, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448240
3.
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial.
Vaccine
; 41(15): 2553-2561, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906404
4.
Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry.
Influenza Other Respir Viruses
; 16(1): 90-100, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520127
5.
Growing teratoma syndrome: Two case reports.
Clin Case Rep
; 10(5): e05803, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582166
6.
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
Lancet Respir Med
; 10(4): 392-402, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114141
7.
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial.
Hum Vaccin Immunother
; 17(12): 5475-5486, 2021 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714720
8.
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6â¯months throughâ¯<18â¯years of age: A randomized controlled phase II dose-finding trial.
Vaccine
; 39(11): 1572-1582, 2021 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610374
9.
Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine
; 37(52): 7596-7609, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31783981
10.
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.
Vaccine
; 35(48 Pt A): 6472-6482, 2017 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150052
11.
Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine
; 34(49): 6015-6026, 2016 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27435386
Resultados
1 -
11
de 11
1
Próxima >
>>